While this study was a retrospective observational study and thus has limitations in establishing causal relationships, it suggests that long-term (over 30 years) combination therapy with ACE inhibitors and β-blockers in the general population may have contributed to the reduction of all-cause and cardiovascular mortality rates among patients with hypertension. The gene discussed is ACE; the disease is hypertensive disorder.